Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Single‐nucleotide polymorphisms are associated with cognitive decline at Alzheimer's disease conversion within mild cognitive impairment patients

1 Jan 2017

Abstract excerpt

INTRODUCTION: The growing public threat of Alzheimer's disease (AD) has raised the urgency to quantify the degree of cognitive decline during the conversion process of mild cognitive impairment (MCI) to AD and its underlying genetic pathway. The aim of this article was to test genetic common variants associated with accelerated cognitive decline after the conversion of MCI to AD. METHODS: In 583 subjects with MCI...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Genetic Associations and Epidemiology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28560309
DOI: 10.1016/j.dadm.2017.04.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 22 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Single‐nucleotide polymorphisms are associated with cognitive decline at Alzheimer's disease conversion within mild cognitive impairment patientsPMID 28560309Read ↗

Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.Semantic proximity Read ↗

Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia.Semantic proximity Read ↗

Genome research in pre-dementia stages of Alzheimer's disease.Semantic proximity Read ↗

Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.Semantic proximity Read ↗

Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.Semantic proximity Read ↗

ANU-ADRI and not Genetic Risk score predicts MCI in a cohort of older adults followed for 12 yearsSemantic proximity Read ↗

Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.Semantic proximity Read ↗

Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer’s DiseaseSemantic proximity Read ↗

Molecular Subtyping of Mild Cognitive Impairment based on Genetic Polymorphism and Gene ExpressionSemantic proximity Read ↗

Predicting 24-Month MCI-to-Alzheimer’s Conversion Using Routine Clinical Assessments Without Neuroimaging or Genetic TestingSemantic proximity Read ↗

Predicting conversion to Alzheimer’s Disease in individuals with Mild Cognitive Impairment using clinically transferable featuresSemantic proximity Read ↗

DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.